Amenorrhea Is Common After Chemotherapy for Breast Cancer Amenorrhea Is Common After Chemotherapy for Breast Cancer
More than half of women treated with chemotherapy for localized breast cancer reported persistent amenorrhea at year 4 after diagnosis, according to a French study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 6, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Ghana: 10,000 Go On Breast Cancer Walk in Tepa
[Ghanaian Times] Kumasi -- About 10,000 health-conscious individuals converged at Tepa, in the Ahafo Ano North Municipality of Ashanti, to take part in this year's breast cancer walk on the theme, 'Breast Cancer Won't Rest, Why Should We?'. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 6, 2022 Category: African Health Source Type: news

Higher CRP Levels Tied to Cognitive Problems in Older Breast Cancer Survivors
(MedPage Today) -- Higher levels of C-reactive protein (CRP) were associated with cognitive problems in older breast cancer survivors, a longitudinal analysis showed. Among participants of the Thinking and Living With Cancer study, breast cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 6, 2022 Category: Hematology Source Type: news

Do you still need chemo for breast cancer?
Some breast cancer patients are getting less chemo — or bypassing it — resulting in less anxiety, fewer side effects, and better outcomes. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 5, 2022 Category: Universities & Medical Training Source Type: news

Age at Menarche, Adult Height, and Mammographic Density Age at Menarche, Adult Height, and Mammographic Density
This paper examines the complex association between age at menarche, adult height, and mammographic density.Breast Cancer Research (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 5, 2022 Category: Radiology Tags: Hematology-Oncology Journal Article Source Type: news

The One Place You're Probably Forgetting When You Do A Breast Check
The physical signs and changes associated with breast cancer aren't limited to the breast tissue. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 5, 2022 Category: Consumer Health News Source Type: news

Study notes fall in mammography volume during COVID-19
Mammography volume fell and a higher proportion of women presented with palpabl...Read more on AuntMinnie.comRelated Reading: Many women don't see disruption from pandemic on breast screening Race, ethnicity tied to risk of delayed follow-up breast imaging ECR: What was COVID-19's effect on radiographers' stress levels? ECR: How has COVID affected cancer screening in Europe? COVID pandemic cut breast cancer screening volume by half (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 5, 2022 Category: Radiology Source Type: news

Breast Cancer Incidence Slowly Increased in Recent Years
TUESDAY, Oct. 4, 2022 -- The incidence rates of breast cancer have increased slowly and breast cancer mortality rates have declined in recent years, with a persistent racial disparity in breast cancer mortality, according to a report published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2022 Category: Pharmaceuticals Source Type: news

Time for Universal Germline Genetic Testing in Breast Cancer Time for Universal Germline Genetic Testing in Breast Cancer
New data suggest that existing restrictive criteria for germline genetic testing for breast cancer deny patients data-informed clinical management.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

U.S. Breast Cancer Death Rates Continue to Fall
TUESDAY, Oct. 4, 2022 -- Breast cancer researchers and clinicians have made tremendous progress in reducing death rates in the past three decades, yet a racial gap persists in the United States. Even with the lower numbers of actual disease compared... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 4, 2022 Category: General Medicine Source Type: news

Fertility Preservation for Women With Breast Cancer Fertility Preservation for Women With Breast Cancer
How do alternative ovarian stimulation protocols for women with breast cancer compare to standard ovarian stimulation in terms of COC yield?Human Reproduction (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2022 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Roche receives FDA approval for first companion diagnostic to identify patients with HER2 low metastatic breast cancer eligible for ENHERTU
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2. These patients with HER2 low status may now be eligible for a targeted treatment, which could significantly improve their outcomes.1,2The PATHWAY anti-HER2 (4B5) test is the only FDA approved companion diagnostic indicated as an aid in the assessment of HER2 low status in metastatic breast cancer patients. These patients may now consider ENHERTU as a treatment option based on the results of the Phase 3 DESTINY-Breast04 trial.3Basel, 4 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug ...
Source: Roche Media News - October 4, 2022 Category: Pharmaceuticals Source Type: news

Role of complex exposures in breast cancer highlighted during workshop
<div class="rxbodyfield">Efforts to better understand the effects of chemical mixtures, communicate risks to the public discussed at event hosted by NIEHS.</div> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - October 4, 2022 Category: Environmental Health Source Type: news

Mayo Clinic Q & amp;A podcast: Surgical options for breast cancer treatment
Most people diagnosed with breast cancer undergo surgery to remove their cancer from the breast as well as have lymph nodes removed as part of their treatment. "Surgical resection of the tumor from the breast and also evaluation of the lymph nodes are used for the vast majority of patients with breast cancer, in particular, those patients where the disease is limited to the breast," says Dr. Judy C. Boughey, a surgical oncologist at Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 4, 2022 Category: Databases & Libraries Source Type: news

TePe supports the Pink Ribbon initiative in favour of cancer awareness and research
This October, oral health company TePe will once again support the Pink Ribbon by offering health-promoting products in favour of cancer research. October is the breast cancer awareness month when organisations and individuals join forces to support cancer research. As an international company committed to sustainability and health awareness, TePe engages in Pink Ribbon initiatives all over the world. Last year, TePe ’s global initiatives contributed over €100,000 to the cause. Katia Saltidou, Marketing Director at TePe, said, “We constantly work to promote long-term health and encourage conscious choices, so natural...
Source: Dental Technology Blog - October 3, 2022 Category: Dentistry Source Type: news